Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic

The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic’s mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday. (Reuters/File)
Short Url
Updated 18 September 2024
Follow

Gavi to buy 500,000 mpox vaccine doses from Bavarian Nordic

  • Gavi said it will spend up to $50 million on the plan, which includes the transportation, delivery and costs of administering the vaccines
  • Around 3.6 million doses of mpox vaccine have already been pledged to the DRC by rich nations which have stockpiles, WHO has said

LONDON: The global vaccine group Gavi will buy 500,000 doses of Bavarian Nordic’s mpox vaccine, its first purchase of the shot to help battle an outbreak in parts of Africa, the group said on Wednesday.
In 2024, there have been more than 25,000 suspected mpox cases and 723 deaths in Africa, mainly in the Democratic Republic of Congo, according to the World Health Organization, which has declared the outbreak a global health emergency.
Gavi, a public-private alliance which co-funds vaccine purchases for low-income countries, said it will spend up to $50 million on the plan, which includes the transportation, delivery and costs of administering the vaccines. The doses are due to be delivered this year.
Around 3.6 million doses of mpox vaccine have already been pledged to the DRC by rich nations which have stockpiles, the World Health Organization has said, but only a small portion has arrived so far. The WHO approved the vaccine for use on Friday last week.
Gavi’s purchase, using a new facility set up after the COVID-19 pandemic to respond quickly to public health emergencies, could speed up the response in Congo and other affected countries.
Also on Wednesday, the Global Fund to Fight AIDS, Tuberculosis and Malaria said it would provide $9.5 million to support Congo with its emergency response at the request of the government there, including surveillance, laboratory systems and risk communication.
The price of the vaccine was not disclosed. Gavi’s $50 million investment would likely equate to less than around $100 per vaccine, because transportation and logistics are included in the total. The figure is lower than previous estimates of the cost.
Gavi chief executive Sania Nishtar said the priority was working with partners “to turn these vaccines into vaccinations as quickly and effectively as possible and, over time, to build a global vaccine stockpile.”
The deal will significantly increase the availability of mpox vaccine for African countries, Bavarian Nordic chief executive Paul Chaplin said. Last week, the company said it would push back some existing orders to 2025, based on US government contracts, to focus on market needs now.
Mpox, which spreads through close contact and typically causes flu-like symptoms and pus-filled lesions, has been a public health problem in parts of Africa for decades. But vaccines have never previously been available outside clinical trials in affected countries in Africa, even after a different strain of the virus spread globally in 2022 and high-income countries used vaccines to help stem the outbreak.


New ‘superfood’ transforms livelihoods in India’s rural east

A farmer harvests makhana, or lotus seeds, in Kapchhahi village in India’s eastern state of Bihar. (Mahesh Mukhia)
Updated 08 December 2025
Follow

New ‘superfood’ transforms livelihoods in India’s rural east

  • Known as fox nut or lotus seed, makhana is rich in protein, dietary fiber, minerals
  • Most of the world’s makhana production is in Bihar, one of India’s poorest states

BIHAR: Wading through knee-deep, stagnant water, Mahesh Mukhia plunges his hands into the mud, pulling up handfuls of sludge that he and others toss into a large, partially submerged basket.

After a while, they shake the basket to drain away the water and debris. What remains is makhana — round black seeds that have lately gained popularity as India’s new superfood.

A regional Indian snack, also known as fox nut or lotus seed, makhana is the edible seed of the prickly waterlily. The plant grows in freshwater ponds and wetlands in southern and eastern Asia.

After makhana seeds are handpicked from pond beds, cleaned, and sun-dried, they are roasted at high heat so their hard black shells crack open and release the white, popcorn-like puffed kernels, which are eaten as snacks or used in dishes.

It has long been known for its nutritional value — high in plant-based protein and dietary fiber, the seeds are also rich in minerals and gluten-free — which over the past few years have helped it gain global attention and are transforming farmlands in Bihar, one of India’s poorest states.

“Earlier, people were not researching it but now, after research, makhana’s nutritional values have been highlighted. Now this is a superfood. That’s why demand is growing everywhere,” said Mahesh Mukhia, a farmer in Kapchhahi village in Bihar’s Darbhanga district, whose family has been harvesting the seeds for generations.

“The difference is that my forefathers did farming in a traditional way, but we’ve learnt to do it in a scientific way,” Mukhia told Arab News.

“There is Bhola Paswan Shastri Agricultural College in the neighboring Purnea district. I went there for training. After I started practicing farming the way I learnt, the yield increased by more than 30 percent.”

Makhana farming is highly labor-intensive, starting with the cultivation of water lilies in shallow ponds. The plants require constant monitoring as they are sensitive to water levels and pests.

Harvesting takes place between August and October. Workers pluck the seeds by hand and then dry them under the sun for several days before they can be processed.

The processing and roasting of makhana also require significant effort. The dried seeds are first de-shelled by manually cracking them, followed by multiple rounds of roasting to make them crisp.

Whole families are involved in the production, which has been expanding since 2020, when the state government introduced the Makhana Development Scheme.

Besides training in farming and processing, growers who cultivate fox nut receive $820 per hectare.

“The rate has also gone up. The makhana that we used to sell at 200-300 ($2-$3) rupees per kg is now selling at 1,000 ($12) or 1,500 rupees per kg,” Mukhia said.

“Makhana farmers are now making a profit. Those who are growing makhana are earning well, those who are popping it are also doing well, and those involved in trading are making profits too. We are getting good demand from everywhere. I just received an order for 25 tonnes recently.”

Bihar currently produces over 85 percent of India’s makhana and accounts for most of the world’s production, according to Ministry of Commerce and Industry estimates.

According to reports by the Indian Brand Equity Foundation and the Agricultural and Processed Food Products Export Development Authority, India accounts for roughly 85 to 90 percent of the world’s production.

Farmland where the crop is grown has increased many times over the past decade and can now be compared to the area covering half of New York City.

More than 600,000 people are involved in the makhana industry in Bihar, according to Niraj Kumar Jha, Darbhanga district’s horticulture officer.

“Earlier, we were cultivating 5,000 hectares in the Kosi and Mithlanchal regions. But now it has expanded to 35,000 hectares, and with many supportive schemes, farmers are increasingly encouraged to grow makhana,” he said.

“We are strengthening our marketing channels. We’ll reach the metro cities as well as world markets ... We can see that makhana is growing very popular, not only in India.”